The Indian government’s updated guidance on a Covid-19 vaccine couldn’t have come at a better time.Yesterday (March 22), the central government wrote to the states asking them to increase the recommended gap between the two doses of Covishield, Serum Institute of India’s (SII) vaccine made using the AstraZeneca vaccine’s master seed. Initially, the second dose of the vaccine was to be taken between four and six weeks of the first dose.But AstraZeneca’s UK trial, which went through several inadvertent anomalies, showed that when the dosing gap was increased to up to 12 weeks, the vaccine’s efficacy against symptomatic disease went up to over 80%. The same efficacy was down to about 55% when t
Hence then, the article about a longer vaccine dose interval has more than one benefit for india was published today ( ) and is available onQuartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( A longer vaccine dose interval has more than one benefit for India )